ArticleClinical rheumatology2026
Subgroups of Kawasaki disease in Japanese patients and temporal change: a retrospective data-driven cluster analysis.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionKawasaki disease is a systemic pediatric vasculitis with a wide range of clinical presentations. Although often viewed as a single disease entity, emerging evidence indicates considerable phenotypic diversity. However, population-specific studies are still limited, especially in high-incidence areas like Japan. This study aimed to identify different clinical subgroups among patients with Kawasaki disease in Japan using cluster analysis.
methodsWe retrospectively reviewed 321 patients diagnosed with Kawasaki disease from 2020 to 2025 at a single center in Japan. Eighteen clinical and laboratory variables were used for principal component analysis and hierarchical clustering. The clusters were compared based on clinical features, treatment responses, and coronary outcomes. Temporal and seasonal trends were also examined.
resultsThree phenotypic clusters were identified: Cluster 1 included younger children with classical Kawasaki disease's features and low treatment resistance; Cluster 2 exhibited hepatobiliary involvement, high intravenous immunoglobulin resistance prediction scores, and frequent need for additional therapy; and Cluster 3 comprised older children with elevated inflammation markers, cervical lymphadenopathy, and delayed diagnosis. Postpandemic, Cluster 3 increased, and seasonal peaks were observed in winter (Cluster 3) and spring (Cluster 2).
conclusionCluster analysis identified distinct Kawasaki disease subtypes in a high-incidence Japanese population, each with unique clinical and temporal features. These findings support using phenotypic clustering to improve risk stratification and guide personalized treatment approaches. Key Points • Three distinct Kawasaki disease phenotypes were identified in Japanese children, each with unique clinical features, biochemical profiles, and treatment responses. • Temporal and seasonal patterns suggest an interplay between environmental triggers and host genetic susceptibility in the expression of KD among Japanese children.
Indexed as
Identifiers
41511676What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.